<DOC>
	<DOCNO>NCT02436304</DOCNO>
	<brief_summary>The purpose study evaluate EXE844 plus tympanostomy tube compare tympanostomy tube base sustained clinical cure end-of-therapy ( EOT ) .</brief_summary>
	<brief_title>Safety Efficacy EXE844 Otic Suspension Otitis Media Time Tympanostomy Tube Insertion ( OMTT ) - Study 2</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<criteria>Recurrent acute otitis medium ( RAOM ) chronic otitis medium effusion ( COME ) eligible bilateral myringotomy tympanostomy tube insertion . Suspected bacterial infection time surgery least 1 ear . Willing refrain water immersion ears follow surgery without use adequate ear protection swimming , bathing , shower waterrelated activity . Legally Authorized Representative ( LAR ) must read sign informed consent . Parent caregiver must agree comply requirement study administer study medication direct , complete require study visit , comply protocol . Other protocolspecified inclusion criterion may apply . Previous otologic otologicrelated surgery within past 30 day ongoing complication . Middle ear pathology either ear otitis medium . Current acute otitis externa ( AOE ) , malignant otitis externa ( MOE ) condition could interfere evaluation study drug . Any systemic disease disorder , complicate factor structural abnormality would negatively affect conduct outcome study base upon assessment Investigator . Known suspect allergy hypersensitivity quinolones active inactive ingredient present medication use study . Other protocolspecified exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>